Literature DB >> 16148154

Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator Inhibitor-1 through a JNK-mediated pathway.

Patrick G Arndt1, Scott K Young, G Scott Worthen.   

Abstract

The neutrophil is of undoubted importance in lung inflammation after exposure to LPS. We have shown recently that systemic inhibition of JNK decreased neutrophil recruitment to the lung after exposure to LPS, although the mechanisms underlying this inhibition are incompletely understood. As plasminogen activator inhibitor-1 (PAI-1) accentuates cell migration, with JNK activation recently shown to up-regulate PAI-1 expression, this suggested that systemic JNK inhibition may down-regulate LPS-induced pulmonary neutrophil recruitment through a decrease in PAI-1 expression. We show in this study that exposure of mice to aerosolized LPS increased PAI-1 expression in the lung and alveolar compartment, which was decreased by pretreatment with the JNK inhibitor SP600125. Exogenous, intratracheally administered PAI-1 prevented the inhibition of pulmonary neutrophil recruitment in the setting of systemic JNK inhibition, thereby suggesting a role for PAI-1 in the JNK-mediated pathway regulating LPS-induced neutrophil recruitment. In addition, PAI-1(-/-) mice had a decrease in neutrophil recruitment to the alveolar compartment after exposure to LPS, compared with wild-type controls, further suggesting a role for PAI-1 in LPS-induced lung inflammation. An increase in the intravascular level of KC is a likely mechanism for the inhibition of pulmonary neutrophil recruitment after LPS exposure in the setting of decreased PAI-1 expression, as systemic KC levels after exposure to LPS were increased in PAI-1-deficient mice and in mice pretreated with SP600125, with augmentation of intravascular KC levels inhibiting neutrophil recruitment to the lung after exposure to LPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148154     DOI: 10.4049/jimmunol.175.6.4049

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Functionally stable plasminogen activator inhibitor-1 in a family with cardiovascular disease and vitiligo.

Authors:  Mehmet Agirbasli; Mesut Eren; Songul Yasar; Kenan Delil; Fatih Goktay; Ebru Toksoy Oner; Douglas E Vaughan
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

2.  Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).

Authors:  Nitin Patel; Nambirajan Sundaram; Mingyan Yang; Catherine Madigan; Vijay K Kalra; Punam Malik
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

3.  NOS2 regulation of LPS-induced airway inflammation via S-nitrosylation of NF-{kappa}B p65.

Authors:  Zachary T Kelleher; Erin N Potts; Mulugu V Brahmajothi; Matthew W Foster; Richard L Auten; W Michael Foster; Harvey E Marshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-01       Impact factor: 5.464

4.  Plasminogen activator inhibitor type 1 expression induced by lipopolysaccharide of Porphyromonas gingivalis in human gingival fibroblast.

Authors:  Hee Sam Na; Eun J Lim; So Y Jeong; Mi H Ryu; Mi Hee Park; Jin Chung
Journal:  J Microbiol       Date:  2014-02-01       Impact factor: 3.422

5.  Plasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages.

Authors:  Weiying Ren; Zhonghui Wang; Feng Hua; Lei Zhu
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 6.  The Basic Science and Molecular Mechanisms of Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Paola Aranda-Valderrama; Ata Murat Kaynar
Journal:  Int Anesthesiol Clin       Date:  2018

7.  Alcohol and inflammatory responses: Highlights of the 2015 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Authors:  Abigail R Cannon; Niya L Morris; Adam M Hammer; Brenda Curtis; Daniel G Remick; Samantha M Yeligar; Lauren Poole; Ellen L Burnham; Todd A Wyatt; Patricia E Molina; Kaku So-Armah; Trinidad Cisneros; Guoshun Wang; Charles H Lang; Pranoti Mandrekar; Elizabeth J Kovacs; Mashkoor A Choudhry
Journal:  Alcohol       Date:  2016-07-25       Impact factor: 2.405

8.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  PAI-1 inhibits neutrophil efferocytosis.

Authors:  Young-Jun Park; Gang Liu; Emmanuel F Lorne; Xia Zhao; Jing Wang; Yuko Tsuruta; Jaroslaw Zmijewski; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

10.  Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment.

Authors:  Li-Fu Li; Chung-Chi Huang; Horng-Chyuan Lin; Ying-Huang Tsai; Deborah A Quinn; Shuen-Kuei Liao
Journal:  Crit Care       Date:  2009-07-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.